BOD SCIENCE LIMITED

0.00%

2.4¢

Market Cap $4.256M

Healthcare Cannabis

Bod Science Limited is an Australia-based cannabis focused drug development and product... Bod Science Limited is an Australia-based cannabis focused drug development and product innovation company. The Company is focused on progressing research and development with a defined clinical trial pathway to commercialize and deliver products for consumer and medical markets. The principal activities of the Company are the development and distribution of therapeutic medicinal cannabis products based on good manufacturing practice (GMP) certified cannabis extracts for medical markets in Australia and the United Kingdom, as well as the development of cannabidiol (CBD) and hemp products for consumer markets in Australia, the United Kingdom, Europe, and United States. The Company’s segments include medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals. The Company offers products for health and wellness, joint/muscle pain and general wellbeing, and stress/anxiety and sleep. The Company also owns the Aqua Phase delivery technology.More

NATURAL MEDICINE LEADERS

The Calmer Co (ASX:CCO) FY25 Revenue Hits $8M, Up 86% on FY24

Latest Threads

Tag

Subject

BOD

Ann: BOD Executes Asset Sale Deed to Sell IP Rights

25/07/25

3.5K

25/07/25

Last post kipper57

3.5K

BOD

Ann: Appendix 4D and Half Year Accounts

25/07/25

291

25/07/25

Last post

ASX News

291

BOD

Ann: Quarterly Activities Update

22/07/25

291

22/07/25

Last post

ASX News

291

BOD

Ann: Appendix 4C Cash Flow Report

22/07/25

262

22/07/25

Last post

ASX News

262

BOD

Ann: Long Term Suspended Entities

16/07/25

278

16/07/25

Last post

ASX News

278

BOD

Ann: Notice to Shareholders

18/06/25

409

18/06/25

Last post

ASX News

409

BOD

Ann: Change in Registered Office and Principal Place of Business

07/05/25

293

07/05/25

Last post

ASX News

293

BOD

Ann: Change of Company Secretary

06/05/25

317

06/05/25

Last post

ASX News

317

See All Discussions

Timeline

Appendix 4D and Half Year Accounts
25 Jul 15:40	Share

Quarterly Activities Update
22 Jul 15:54	Share

Appendix 4C Cash Flow Report
22 Jul 15:54	Share

Long Term Suspended Entities
16 Jul 16:15	Share

Notice to Shareholders
18 Jun 10:24	Share

Change in Registered Office and Principal Place of Business
07 May 14:06	Share

Change of Company Secretary
06 May 10:06	Share

Long Term Suspended Entities
09 Apr 16:18	Share

Quarterly Activities/Appendix 4C Cash Flow Report
09 Apr 16:14	Share

Notice to Shareholders
19 Mar 16:37	Share

Quarterly Activities/Appendix 4C Cash Flow Report
24 Jan 15:49	Share

BOD Executes Asset Sale Deed to Sell IP Rights
24 Jan 12:44	Share

Long Term Suspended Entities
22 Jan 16:20	Share

Notice to Shareholders
18 Dec 16:31	Share

Notification of cessation of securities - BOD
12 Nov 15:07	Share

BOD Executes Binding Share Purchase Agreement
05 Nov 12:11	Share

Appendix 4G and Corporate Governance Statement
01 Nov 16:58	Share

FY24 Appendix 4E and Annual Report
01 Nov 16:56	Share

Deferral of Annual General Meeting
31 Oct 10:31	Share

Long Term Suspended Entities
18 Oct 16:15	Share

Quarterly Activities/Appendix 4C Cash Flow Report
17 Oct 10:03	Share

Notice to Shareholders
04 Oct 12:01	Share

Delay in Lodgement of Appendix 4E and Full Year Accounts
30 Sep 10:08	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.